Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

CUSIP: 71722W107

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
+2,918,153
Put/Call ratio
136%
SEC-reported price per share
$33.22
Number of holders
75
Value change
+$96,707,884
Number of buys
45
Open additional details 1 more signal available
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
78,837,943

Security key

71722W107

Report period

Q4 2020

Institutions

75

Top holders

10

Ownership snapshot

Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FRAZIER MANAGEMENT LLC
Disclosed value leader
FRAZIER MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F Lead comparable stake: 7.4% Showing 1-6 of 15 holder rows.

Quick read

FRAZIER MANAGEMENT LLC leads the comparable SEC ownership view at 7.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRAZIER MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
FRAZIER MANAGEMENT LLC 7.4%
RA CAPITAL MANAGEMENT, L.P. 4.9%
Invesco Ltd. 2.6%
Medicxi Ventures Management (Jers... 2.6%
JANUS HENDERSON GROUP PLC 2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FRAZIER MANAGEMENT LLC
13F
Company
13F
7.4%
$213,691,000
5,827,415 shares
30 Sep 2020
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
4.9%
$140,263,000
3,825,008 shares
30 Sep 2020
Invesco Ltd.
13F
Company
13F
2.6%
$76,280,000
2,080,178 shares
30 Sep 2020
Medicxi Ventures Management (Jersey) Ltd
13F
Company
13F
2.6%
$75,828,000
2,067,861 shares
30 Sep 2020
JANUS HENDERSON GROUP PLC
13F
Company
13F
2%
$57,538,000
1,568,796 shares
30 Sep 2020
Abingworth LLP
13F
Company
13F
1.5%
$44,516,000
1,203,135 shares
30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
75
Shares
24,534,138
Rows available
75
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
57
Q4 2020 holders
75
Holder diff
18
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .